위스콘신의 흑색종 임상 시험
흑색종 관련 연구 20개가 위스콘신 내 여러 지역에서 참여자를 모집하고 있습니다.
위스콘신의 도시
- Madison연구 15개
- Milwaukee연구 7개
- Green Bay연구 6개
- Wausau연구 6개
- Stevens Point연구 4개
- Eau Claire연구 3개
- Sheboygan연구 3개
- La Crosse연구 3개
공식 연구 텍스트(영어)
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
- UW Hospital and Clinics, Madison
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07281924BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Duluth Clinic Ashland, Ashland
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- 외 17개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- University of Wisconsin Carbone Cancer Center, Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06246916Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Marshfield Medical Center-Marshfield, Marshfield
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- Medical College of Wisconsin, Milwaukee
- 외 4개
피험자 모집 중3상
75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0134, Madison
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Langlade Hospital and Cancer Center, Antigo
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- Gundersen Lutheran Medical Center, La Crosse
- 외 11개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Wisconsin-Madison Carbone Cancer Center, Madison
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07287917A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- The Board of Regents of the University of Wisconsin, Madison
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 외 46개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069Project: Every Child for Younger Patients With Cancer
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- 외 1개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699Neoadjuvant Darovasertib in Primary Uveal Melanoma
- University of Wisconsin Health, Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Aspirus Langlade Hospital, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Saint Elizabeth Hospital, Appleton
- 외 61개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
- University of Wisconsin Hospitals and Clinics (UWHC), Madison
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06199713SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774In Vivo Liquid Biopsy of Melanoma (Cytophone)
- SSM Health Dean Medical Group Specialty Services, Madison
피험자 모집 중건강한 지원자 환영
18세 ~ 80세 · 모든 성별 · 2025. 3. 11. 업데이트됨 · NCT06488365Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
- University of Wisconsin Carbone Cancer Center, Madison
- Marshfield Medical Center - Marshfield, Marshfield
- 외 3개
피험자 모집 중
18세 이상 · 모든 성별 · 2024. 11. 27. 업데이트됨 · NCT03860883ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.